Showing results (61-70 of 192) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Cell-Free DNA Modification Dynamics in Abiraterone Acetate-Treated Prostate Cancer PatientsJuozas Gordevičius, Algimantas Kriščiūnas, Daniel E Groot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 29, 2012
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason gradeMaisa Yoshimoto, Keyue Ding, Joan M Sweet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2011
PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapyMichael Fraser, Helen Zhao, Kaisa R Luoto, et al.
BJU International|February 9, 2012
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkersNeesha C Dhani, Urban Emmenegger, Laurie Adams, et al.
Cancer|April 2, 2021
Examining the ability of the Cancer and Aging Research Group tool to predict toxicity in older men receiving chemotherapy or androgen-receptor-targeted therapy for metastatic castration-resistant prostate cancerShabbir M H Alibhai, Henriette Breunis, Aaron R Hansen, et al.
European Urology|February 11, 2014
Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance statusArun A Azad, Bernhard J Eigl, Raya Leibowitz-Amit, et al.
Cancer Immunology Research|January 30, 2016
Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic MelanomaLeila Khoja, Catherine Maurice, MaryAnne Chappell, et al.
The Prostate|August 12, 2014
Retreatment of men with metastatic castrate-resistant prostate cancer with abirateroneRaya Leibowitz-Amit, Nimira Alimohamed, Francisco E Vera-Badillo, et al.
The Prostate|January 16, 2016
Study of testosterone-guided androgen deprivation therapy in management of prostate cancerSaroj Niraula, Arnoud J Templeton, Francisco E Vera-Badillo, et al.
Epigenomics|July 12, 2022
A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancerMadonna R Peter, Misha Bilenky, Yuliang Shi, et al.
Pageof 20